This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Fortune 500 Pharmaceutical Company Expands Use Of InContact Cloud Contact Center Software Across Multiple Divisions

Stocks in this article: SAAS





SALT LAKE CITY, May 29, 2013 /PRNewswire/ -- inContact (NASDAQ: SAAS), the leading provider of cloud contact center software and contact center agent optimization tools, today announced that a current Fortune 500 customer is adding another division to be supported by inContact. During the selection process, inContact provided an ROI model and level of functionality that would not be possible with the premise-based call center solution the company had been using previously.

(Logo: http://photos.prnewswire.com/prnh/20120216/LA54560LOGO)

Serving healthcare providers and patients, the pharmacy services division has stringent requirements for security and redundancy that are mandated by government, legal and industry regulations. inContact was able to satisfy those security needs and provides a world-class cloud infrastructure that includes geographically redundant data centers and a carrier-grade telecom infrastructure that is owned, managed and monitored 24/7/365 by inContact employees. In addition to cloud Automatic Call Distribution and Workforce Management, inContact will support greater agent efficiency by integrating the inContact cloud universal queue directly with CRM and other business systems so that agents have all the information they need to personalize the customer care experience.

"There is unprecedented pressure on the bottom line for healthcare organizations," said Paul Jarman, CEO of inContact. "Our cloud contact center software has a proven cost-efficiency model. Now companies can get advanced features for managing workflow and agent productivity with a pay-as-you-go approach that makes sense for many companies."

Jarman added: "inContact has a portfolio of healthcare customers and we are rock-solid in our security and reliability which is backed up with enterprise-grade infrastructure and a published uptime guarantee of 99.99%."

Additional Information





1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,233.05 -183.80 -1.06%
S&P 500 2,005.38 -15.87 -0.79%
NASDAQ 4,657.3590 -26.0480 -0.56%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs